
Digital R&D
Defining the path to TBK1 inhibition with QSAR modeling
Why are there no FDA approved TBK1 (TANK-binding kinase) inhibitors on the market, despite the key role it plays in the pathophysiology of many diseases.
Read CAS InsightsAccelerating your scientific progress by revealing unique connections and perspective at the intersection of science, technology, and innovation.